Open-label extension trial of the safety and tolerability of OROSO methylphenidate in adults with ADHD - the long-acting methylphenidate in adult ADHD (lamda) trial

被引:0
|
作者
Kooij, S.
Medori, R.
Buitelaar, J.
Ramos-Quiroga, J. A.
Lee, E.
Casas, M.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:XCIII / XCIII
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of OROSO methylphenidate in adults with ADHD the long-acting methylphenidate in adult ADHD (lamda) trial
    Medori, R.
    Kooij, S.
    Ramos-Quiroga, J. A.
    Buitelaar, J.
    Lee, E.
    Casas, M.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (07) : XCII - XCIII
  • [2] Open-label (OL) extension trial of the safety and tolerability of OROS® methylpheniclate in adults with ADHD -: the long-acting methylpheniclate in adult ADHD (LAMDA) trial
    Philipsen, A.
    Trott, G. E.
    Roesler, M.
    Gerwe, M.
    Lee, E.
    Medori, R.
    Schauble, B.
    PHARMACOPSYCHIATRY, 2007, 40 (05) : 247 - 248
  • [3] Efficacy and safety of OROS® methylpheniclate in adults with ADHD:: the long-acting methylphenidate in adult ADHD (LAMDA) trial
    Roesler, M.
    Trott, G. E.
    Philipsen, A.
    Gerwe, M.
    Lee, E.
    Medori, R.
    Schauble, B.
    PHARMACOPSYCHIATRY, 2007, 40 (05) : 248 - 248
  • [4] Effectiveness and compatibility of OROS®-methylphenidate for adult with ADHS -: The long-acting methylphenidate in adult ADHD (LAMDA) trial
    Gerwe, Martin
    Philipsen, A.
    Roesler, M.
    Sobanski, E.
    Schaeuble, B.
    Medori, R.
    Trott, G. -E.
    NERVENARZT, 2007, 78 : 208 - 209
  • [5] Offene extensions-study for compatibility of OROS-methylphenidate for adult with ADHD -: The long-acting methylphenidate in adult ADHD (LAMDA) trial
    Gerwe, Martin
    Roesler, M.
    Trott, G. -E.
    Philipsen, A.
    Sobanski, E.
    Medori, R.
    Schaeuble, B.
    NERVENARZT, 2007, 78 : 208 - 208
  • [6] A PROSPECTIVE OPEN-LABEL TRIAL OF LONG-ACTING LIQUID METHYLPHENIDATE FOR THE TREATMENT OF ADHD IN INTELLECTUALLY CAPABLE ADULTS WITH ASD
    Joshi, Gagan
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S331 - S331
  • [7] An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Adults With ADHD
    Ni, Hsing-Chang
    Lin, Yu-Ju
    Gau, Susan Shur-Fen
    Huang, Hui-Chun
    Yang, Li-Kuang
    JOURNAL OF ATTENTION DISORDERS, 2017, 21 (01) : 27 - 39
  • [8] An open-label trial of OROS methylphenidate,in adults with late-onset ADHD
    Biederman, Joseph
    Mick, Eric
    Spencer, Thomas
    Surman, Craig
    Hammerness, Paul
    Doyle, Robert
    Dougherty, Megan
    Aleardi, Megan
    Schweitzer, Karl
    CNS SPECTRUMS, 2006, 11 (05) : 390 - 396
  • [9] Atomoxetine and methylphenidate treatment in children with ADHD: A prospective, randomized, open-label trial
    Kratochvil, CJ
    Heiligenstein, JH
    Dittmann, R
    Spencer, TJ
    Biederman, J
    Wernicke, J
    Newcorn, JH
    Casat, C
    Milton, D
    Michelson, D
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2002, 41 (07): : 776 - 784
  • [10] A Multicenter, Open-Label Trial to Evaluate the Quality of Life in Adults With ADHD Treated With Long-Acting Methylphenidate (OROS MPH): Concerta Quality of Life (CONQoL) Study
    Mattos, Paulo
    Louza, Mario Rodrigues
    Fernandes Palmini, Andre Luis
    de Oliveira, Irismar Reis
    Rocha, Fabio Lopes
    JOURNAL OF ATTENTION DISORDERS, 2013, 17 (05) : 444 - 448